Go Pro
OTCMKTS:AMBBY

Ambu A/S 11/5/2024 Earnings Report

Ambu A/S logo
$10.25 0.00 (0.00%)
As of 09/18/2026

Ambu A/S EPS Results

Actual EPS
-$0.08
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Ambu A/S Revenue Results

Actual Revenue
$204.32 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Ambu A/S Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Ambu A/S Earnings Headlines

Ambu AS ADR AMBBY
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
3 European Stocks Estimated To Be Undervalued By Up To 47.6%
European Growth Companies With Up To 34% Insider Ownership
See More Ambu A/S Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ambu A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ambu A/S and other key companies, straight to your email.

About Ambu A/S

Ambu A/S (OTCMKTS:AMBBY) is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. The company focuses on reducing the need to reprocess reusable equipment while supporting clinical procedures in areas such as endoscopy, anesthesia and patient monitoring.

Ambu’s product portfolio includes disposable endoscopes and related visualization systems, airway management products, anesthesia equipment and devices used for patient monitoring and diagnostics. Its endoscopy offerings are used in pulmonary, gastrointestinal and other clinical applications, while its anesthesia and airway products support the care of patients before, during and after medical procedures.

Founded in 1937 by Holger Hesse, Ambu is headquartered in Ballerup, Denmark, and serves healthcare markets internationally, including Europe, North America and the Asia-Pacific region. The company is led by Chief Executive Officer Britt Meelby Jensen, who has served in that role since 2023.

View Ambu A/S Profile